Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus
- 15 March 1992
- Vol. 69 (6) , 1424-1431
- https://doi.org/10.1002/1097-0142(19920315)69:6<1424::aid-cncr2820690620>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinomaGynecologic Oncology, 1990
- DNA Ploidy in Endometrial Carcinoma: Major Objective Prognostic FactorMayo Clinic Proceedings, 1990
- Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicatorGynecologic Oncology, 1989
- Flow cytometric DNA analysis of stage I endometrial carcinomaGynecologic Oncology, 1989
- Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patientsGynecologic Oncology, 1984
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Predictors of Recurrence in Stage I (T1N0M0) Breast CarcinomaAnnals of Surgery, 1981
- TREATMENT OF ADENOCARCINOMA OF THE ENDOMETRIUMObstetrical & Gynecological Survey, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958